ImmunologybioRxiv
A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors
T. Yamauchi, T. Hoki, T. Oba…·F. Ito
The paper identifies CX3CR1 expression on circulating CD8+ T cells as a biomarker predicting response to immune checkpoint inhibitor therapy in NSCLC patients.
DOI 10.1038/s41467-021-21619-0